953 related articles for article (PubMed ID: 9375586)
41. T cell activation by a bispecific anti-CD3/anti-major histocompatibility complex class I antibody.
Roosnek E; Tunnacliffe A; Lanzavecchia A
Eur J Immunol; 1990 Jun; 20(6):1393-6. PubMed ID: 2142461
[TBL] [Abstract][Full Text] [Related]
42. Human T-cell-porcine endothelial cell interactions induce human Th1 cytokines and porcine activation markers.
Coleman TS; Pittman HK; Purser SM; Haisch CE; Verbanac KM
J Surg Res; 2001 May; 97(2):184-91. PubMed ID: 11341797
[TBL] [Abstract][Full Text] [Related]
43. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
44. Antigen-specific and -nonspecific mitogenic signals in the activation of human T cell clones.
Nisbet-Brown ER; Lee JW; Cheung RK; Gelfand EW
J Immunol; 1987 Jun; 138(11):3713-9. PubMed ID: 2953789
[TBL] [Abstract][Full Text] [Related]
45. Human leukocyte antigen-class II-positive human corneal epithelial cells activate allogeneic T cells.
Iwata M; Yagihashi A; Roat MI; Zeevi A; Iwaki Y; Thoft RA
Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):3991-4000. PubMed ID: 7960581
[TBL] [Abstract][Full Text] [Related]
46. Limited costimulatory molecule expression on renal tubular epithelial cells impairs T cell activation.
Waeckerle-Men Y; Starke A; Wahl PR; Wüthrich RP
Kidney Blood Press Res; 2007; 30(6):421-9. PubMed ID: 17975322
[TBL] [Abstract][Full Text] [Related]
47. Immunochemical and biochemical characterization of purified canine interferon-gamma. Production of a monoclonal antibody, affinity purification, and its effect on mixed lymphocyte culture and mixed lymphocyte kidney culture reactions.
Fuller L; Fernandez J; Zheng S; Carreno M; Esquenazi V; Yang WC; Miller J
Transplantation; 1992 Jan; 53(1):195-202. PubMed ID: 1531093
[TBL] [Abstract][Full Text] [Related]
48. Alloantigenicity of human endothelial cells. III. Quantitated indirect presentation of endothelial alloantigens to human helper T lymphocytes.
Adams PW; Lee HS; Waldman WJ; Sedmak DD; Orosz CG
Transplantation; 1994 Aug; 58(4):476-83. PubMed ID: 7915443
[TBL] [Abstract][Full Text] [Related]
49. CD28-mediated costimulation is necessary for the activation of T cell receptor-gamma delta+ T lymphocytes.
Sperling AI; Linsley PS; Barrett TA; Bluestone JA
J Immunol; 1993 Dec; 151(11):6043-50. PubMed ID: 8245449
[TBL] [Abstract][Full Text] [Related]
50. The antigen presentation function of renal tubular epithelial cells.
Kelley VR; Singer GG
Exp Nephrol; 1993; 1(2):102-11. PubMed ID: 8081954
[TBL] [Abstract][Full Text] [Related]
51. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation.
Chaux P; Moutet M; Faivre J; Martin F; Martin M
Lab Invest; 1996 May; 74(5):975-83. PubMed ID: 8642792
[TBL] [Abstract][Full Text] [Related]
52. Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells.
Waldman WJ; Knight DA
Am J Pathol; 1996 Jan; 148(1):105-19. PubMed ID: 8546198
[TBL] [Abstract][Full Text] [Related]
53. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
[TBL] [Abstract][Full Text] [Related]
54. Influence of MHC class I molecules on T-cell proliferation induced by CD3 or Thy-1 stimulation.
Amirayan N; Furrie E; Deleuil F; Mellor A; Leserman L; Machy P
Immunology; 1995 Sep; 86(1):71-8. PubMed ID: 7590885
[TBL] [Abstract][Full Text] [Related]
55. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions.
Sugita S; Usui Y; Horie S; Futagami Y; Aburatani H; Okazaki T; Honjo T; Takeuchi M; Mochizuki M
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2862-70. PubMed ID: 19182257
[TBL] [Abstract][Full Text] [Related]
56. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
57. MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain.
Ilkovitch D; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2004 Jun; 53(6):525-32. PubMed ID: 14730400
[TBL] [Abstract][Full Text] [Related]
58. Human retinal pigment epithelial cells inhibit proliferation and IL2R expression of activated T cells.
Kaestel CG; Jørgensen A; Nielsen M; Eriksen KW; Ødum N; Holst Nissen M; Röpke C
Exp Eye Res; 2002 May; 74(5):627-37. PubMed ID: 12076084
[TBL] [Abstract][Full Text] [Related]
59. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells.
Nikcevich KM; Gordon KB; Tan L; Hurst SD; Kroepfl JF; Gardinier M; Barrett TA; Miller SD
J Immunol; 1997 Jan; 158(2):614-21. PubMed ID: 8992975
[TBL] [Abstract][Full Text] [Related]
60. Functional consequences of costimulation by ICAM-1 on IL-2 gene expression and T cell activation.
Zuckerman LA; Pullen L; Miller J
J Immunol; 1998 Apr; 160(7):3259-68. PubMed ID: 9531282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
